Accurate Education – LA Marijuana Products – Edible Products

LA Marijuana Products:

Edible Products

Because edible forms of medical marijuana are prepared differently, leading to different constituents, and are metabolized differently, leading to different pharmacologic effects, it is important to understand how edible forms of medical marijuana differ from inhaled forms and other pharmaceutical forms of medical marijuana.

 

Understanding Edibles

Marijuana (Cannabis) – Oral Use (Edibles)

 

LA Marijuana Products

LA Marijuana Products: Introductory Principles

LA Marijuana Products: Tinctures

LA Marijuana Products: Vape Cartridges & Vaporizers

LA Marijuana Products: Ilera Vape Formulations

LA Marijuana Products: RSO Formulations

LA Marijuana Products: Flower Products

LA Marijuana Products: Edible Products

LA Marijuana Products: Topical Products

 

 

Links to other Pertinent Educational Pages:

Links to ALL Marijuana Educational Pages

For those interested in pursuing a trial of therapy with cannabis-based products,  first read:

Medical Marijuana  – Marijuana Use Introduction

Marijuana (Cannabis) – Potential for Harm 

Marijuana (Cannabis) – Side Effects and Drug Interactions

Medical Marijuana – Cannabinoids and Opioids

 

Marijuana Pharmacies/Dispensaries in Louisiana

Marijuana Pharmacies

 

 

The medical information on this site is provided as a resource for information only, and is not to be used or relied upon for any diagnostic or treatment purposes and is not intended to create any patient-physician relationship.  Readers are advised to seek professional medical guidance regarding the diagnosis and treatment of their medical concerns. 

The only “edible” (specifically made for oral ingestion) THC products currently available in LA are Wellcana’s “gummies.”  Although gummies (or other marijuana-based products in the form of candy or other highly palatable food products) are not recommended, this is not to say that edible forms are not recommended. In fact, orally consumed edible cannabis-based products, particularly those with THC, offer distinct differences and advantages compared to vape products. For many, the orally ingested method of using cannabis based products is preferred for both improved effectiveness and tolerability.

See, Marijuana (Cannabis): Oral Use (Edibles)

 

Tinctures

Tinctures are in fact considered edible products when swallowed and may offer the advantage of both more rapid sublingual absorption followed by a delayed ingested absorption.  But unfortunately the currently available tinctures are lacking in desirable dosing options, meaningful terpene profile information and for many they are not very palatable or well tolerated when used alone.

 

RSO Products

The RSO products currently available in liquid form to be used with refillable cartridges for vaping can be orally ingested when mixed with a food product IF very careful attention is paid to dosing.

 

Marijuana Flowers

As a plant, product marijuana flowers are usually smoked or vaped predominately by most people. However, the marijuana flowers may be prepared in ways to provide oral, edible forms. Recreational marijuana users have developed the culinary use of marijuana to an art form over the last few decades. In-depth discussion of how to prepare flowers and buds for the most effective and palatable use is beyond the scope of this site, but one should be aware that preparation of marijuana flowers is a viable approach to achieving effective and well-tolerated medical use of cannabis.

See: Marijuana: Oral Use (Edibles)

 

Gummies

Because they taste good and are presented as candy, gummies are not recommended due to their tendency to reinforce unnecessary increased dosing and greater potential for undesirable side effects. Furthermore, edibles are more likely to be accidentally ingested by children, pets or others who may mistake them for food. Does anyone think Percocet should be provided as a gummy?

While gummies will not be recommended/prescribed at Accurate Clinic, the following information is nevertheless provided. After ingesting a gummy it may take a long time (1-2 hours) for the effect to fully kick in, while the duration of effect may persist up to 6-8 hours.

For important information regarding the use of gummies on an empty stomach vs. with food,

See:  Marijuana:(Cannabis) Oral Use (Edibles)

 

The gummies are available in 2 strawberry flavored formulations:

1. 1. 600 mg bag: THC only (20 mg/piece) Qty: #30/bag
   2. 300 mg bag: THC-CBD (balanced formulation: 10mg THC / 10mg CBD per piece) Qty: #30/bag

 

 

 

Resources:

National Academy of Sciences

The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research

 

These lay-person websites appear to be good resources for exploring medical marijuana:

1. www.GreenCamp.com
2. www.Healer.com
3. www.MedicalJane.com
4. www.ProjectCBD.org
5. analytical360.com
6. www.leafly.com

 

 

References:

Epidiolex (cannabidiol)

1. FDA approves CBD drug – Epidiolex – The Washington Post

 

Marinol (dronabinol)

1. Marinol – dronabinol

 

 Marijuana – Sativs vs Indica

1. The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products – 2018

 

Medical Marijuana – Federal Law

1. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law – 2017

 

 

Medical Marijuana – Dosing

1. Practical considerations in medical cannabis administration and dosing – 2018
2. Measuring cannabis consumption – Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU) – 2017
3. Quantifying Cannabis – A Field Study of Marijuana Quantity Estimation – 2018
4. Bayesian inference for the distribution of grams of marijuana in a joint. – PubMed – NCBI – 2016
5. Delphi Consensus – recommendations on dosing and administration of medical cannabis to treat chronic pain – results of a modified Delphi process – 2021
6. Delphi Consensus – A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics – 2021
7. Delphi Consensus – Clinical experience and COI disclosures
8. Delphi Consensus – Dosing and Administration of Medical Cannabis- Physician Survey
9. Delphi Consensus – Virtual Voting Round 2 Results Delphi Consensus – Voting Round 1 Results
10. Consensus‐based recommendations for titrating cannabinoids and tapering opioids for chronic pain control – 2021

 

Medical Marijuana – Louisiana Law

1. Louisiana-2016-SB180-Chaptered
2. HOUSE BILL NO. 225 – 2017 Regular Session
3. Louisiana medical marijuana expansion bill signed into law – May 20, 2016
4. Now in Effect, Louisiana Medical Marijuana Law Shields Patients and Caregivers from Prosecution – Aug 5, 2016
5. Louisiana-2016-SB180-Chaptered

 

Cannabidiol (CBD)- Overviews

1. CANNABIDIOL (CBD) Pre-Review Report WHO 2017
2. Cannabidiol – State of the art and new challenges for therapeutic applications. – 2017 PubMed – NCBI

 

CBD – Anxiety

1. Overlapping Mechanisms of Stress-Induced Relapse to Opioid Use Disorder and Chronic Pain – Clinical Implications – 2016
2. Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System – 2016
3. Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders. – PubMed – NCBI
4. Review of the neurological benefits of phytocannabinoids – 2018
5. Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders – 2017
6. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. – PubMed – NCBI
7. Evidences for the Anti-panic Actions of Cannabidiol – 2017
8. Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug – 2012
9. Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients – 2011

 

CBD – Interaction with THC

1. Cannabidiol: a promising drug for neurodegenerative disorders? – PubMed – NCBI
2. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis – 2015
3. Taming THC – potential cannabis synergy and phytocannabinoid-terpenoid entourage effects – 2011
4. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. – PubMed – NCBI

 

 

CBD – Metabolites

1. Human Metabolites of Cannabidiol – A Review on Their Formation, Biological Activity, and Relevance in Therapy – 2016

 

CBD – Drug-Metabolic Interactions

1. Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6 – 2011
2. The Effect of CYP2D6 Drug-Drug Interactions on Hydrocodone Effectiveness – 2014 
3. Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana – 2006

 

Medical Marijuana – Prescribing Guidelines

1. Simplified guideline for prescribing medical cannabinoids in primary care – Canadian Family Physician – 2018
2. Physician Recommendation of Medical Cannabis Guidelines Calif Medical Assoc – 2011
3. Prescribing smoked cannabis for chronic noncancer pain. Preliminary recommendations – Canadian Family Physician – 2014

 

 

Medical Marijuana – Opioids

1. Use-of-Prescription-Pain-Medications-Among-Medical-Cannabis-Patients
2. It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis – 2018
3. Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort – 2018
4. Patterns and correlates of medical cannabis use for pain among patients prescribed long-term opioid therapy. – PubMed – NCBI
5. Associations between medical cannabis and prescription opioid use in chronic pain patients – A preliminary cohort study – 2017
6. The prevalence and significance of cannabis use in patients prescribed chronic opioid therapy: a review of the extant literature. – PubMed – NCBI
7. The use of cannabis in response to the opioid crisis: A review of the literature. – PubMed – NCBI
8. Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999–2010 – 2014
9. Rationale for cannabis-based interventions in the opioid overdose crisis – 2017
10. Cannabis and the Opioid Crisis – 2018
11. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. – PubMed – NCBI
12. Cannabinoid–Opioid Interaction in Chronic Pain
13. Synergistic interactions between cannabinoid and opioid analgesics. – PubMed – NCBI
14. FDA approves CBD drug – Epidiolex – The Washington Post

 

Medical Marijuana, Chronic Pain – Cannabinoids & Palmitoylethanolamide

1. Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions – a case series – 2012
2. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent – 2013
3. Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis – 2015
4. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol,… – PubMed – NCBI 2001
5. Endocannabinoid-related compounds in gastrointestinal diseases – 2018
6. ‘Entourage’ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors – 2008
7. Medical Cannabis and Cannabinoids- An Option for the Treatment of Inflammatory Bowel Disease and Ca
   ncer of the Colon? – 2018
8. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide – 2001
9. Phytocannabinoids beyond the Cannabis plant – do they exist? – 2010
10. Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in c… – PubMed – NCBI
11. Cannabinoids as pharmacotherapies for neuropathic pain – from the bench to the bedside. – 2009
12. Correction – Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome – 2018
13. Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity – involvement of the CB2 receptor – 2017
14. Mast cells, glia and neuroinflammation – partners in crime? – 2013
15. A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia – A Review – 2018

 

Medical Marijuana –Misc

1. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. – PubMed – NCBI
2. Cannabis and cannabis extracts – greater than the sum of their parts? – 2001
3. Medical cannabis and mental health: A guided systematic review. 2016 – PubMed – NCBI
4. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. – PubMed – NCBI
5. Cannabis-conclusions – 2017 National Academy of Sciences
6. Cannabis-chapter-highlights – 2017 National Academy of Sciences
7. Cannabis-report-highlights – 2017 National Academy of Sciences
8. Clinical Endocannabinoid Deficiency (CECD): Can this Concept Explain Therapeutic Bene ts of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions?-2004
9. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. – PubMed – NCBI
10. Cannabis use and cognitive function: 8-year trajectory in a young adult cohort. – PubMed – NCBI
11. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. – PubMed – NCBI
12. Cannabinoids and Cytochrome P450 Interactions. – PubMed – NCBI Pharmacogenetics of Cannabinoids – 2018
13. Systematic review of systematic reviews for medical cannabinoids – 2018
14. Adverse effects of medical cannabinoids – a systematic review – 2008
15. Cannabimimetic effects modulated by cholinergic compounds. – PubMed – NCBI
16. Antagonism of marihuana effects by indomethacin in humans. – PubMed – NCBI
17. Pharmacokinetics and pharmacodynamics of cannabinoids. – PubMed – NCBI
18. Clinical Pharmacodynamics of Cannabinoids – 2004
19. Affinity and Efficacy Studies of Te
    trahydrocannabinolic Acid A at Cannabinoid Receptor Types One and Two. – 2017
20. Quality Control of Traditional Cannabis Tinctures – Pattern, Markers, and Stability – 2016
21. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. – PubMed – NCBI
22. Pharmacology of Cannabinoids
23. Current-status-and-future-of-cannabis-research-Clin-Researcher-2015
24. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems – A Clinical Review – 2015

 

Medical Marijuana – Products

Medical Marijuana – Product Evaluation

1. The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products – 2018
2. Quality Control of Traditional Cannabis Tinctures – Pattern, Markers, and Stability – 2016

 

Medical Marijuana – Flower/Bud Products

Wellcana (Good Day Farm):

1. Grease Monkey Flyer
2. Lilac Diesel Flyer

 

Medical Marijuana – Topical Products

1. Soothe Flyer
2. Breathe Flyer

 

 

Emphasis on Education

 

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

 

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

 

Should you wish more information regarding any of the subjects listed – or not listed –  here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

 

For more information, please contact Accurate Clinic.

 

Supplements recommended by Dr. Ehlenberger may be purchased commercially online or at Accurate Clinic.

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.

Accurate Supplement Prices

 

 

.